Science Magazine: Novozymes is top three best employer in the world

Science Magazine ranks Novozymes among the companies with the best reputations as employers.

Science Magazine’s annual Top Employers Survey 2018 polls employees in the biotechnology, biopharmaceutical, pharmaceutical and related industries.  For the fourth consecutive year, Novozymes ranks among the top ten best companies in the world.

"We are very honored to once again be recognized as one of the most attractive employers. Novozymes develops biological solutions to some of the most urgent challenges of the world and our employees are very proud of what we do and motivated by our purpose to contribute to a more sustainable world," says Claus Crone Fuglsang, Chief Science Officer at Novozymes.

Respondents to the web-based survey rated companies based on a number of characteristics, including financial strength, easy adaptation to change and a research-driven environment. They were also asked whether the company treats its employees with respect and if its work-culture values align with employees’ personal values.

"An organization is only as good as its people and the success of our company relies on our dedicated and competent employees. Their recognition of Novozymes as a great place to work, where you can develop personally and professionally, means a lot for our ability to attract talents and remain a global game-changing company," says Claus Crone Fuglsang.

World leading bio tech company

Novozymes is the world’s largest producer of industrial enzymes and microorganisms. Its biotechnology is used by companies all over the world to save on energy, water and raw materials in a wide range of products. From laundry detergents, to biofuels, animal feed and crops. In 2017, the worldwide application of Novozymes’ technology helped customers reduce their CO₂ emissions by an estimated 76 million tons, equivalent to taking 32 million cars off the road.

One in five of the 6,500 employees work in research and development and Novozymes invests 13% of its total revenue into research each year.

"We are an innovation driven company and keep expanding into new areas which helps grow top line and profitability. Over the last years, 25% or more of our sales derive from new products.  Therefore, it means a lot for us to be recognized as a top science employer," says Claus Crone Fuglsang.

About the survey

  • Science Magazine is the academic journal of the American Association for the Advancement of Science (AAAS) and one of the world's top scientific publications.
  • The Top Employers Survey 2018 is based on over 8,000 completed surveys from readers of Science and other survey invitees. Survey respondents came from North America (63%), Europe (24%), and Asia/Pacific Rim (9%); 93% work in biotechnology, biopharmaceutical, and pharmaceutical companies.
  • For the complete ranking, go to Science magazine

Related articles

Novonesis HQ in Lyngby, Denmark
01.02.24 | 8 minute read

Legacy Novozymes delivers solid last full-year results

Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks the last financial reporting from legacy Novozymes, and the new company, Novonesis, is already a reality.
Novonesis office
29.01.24 | 6 minute read

The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner

Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for better business, healthier lives, and a healthier planet. The combined company brings together 10,000 people worldwide and an expertise that spans more than 30 different industries. Novonesis is already assisting companies around the world in meeting both business needs and the needs of the planet.
Novonesis
13.12.23 | 8 minute read

Novozymes and Chr. Hansen announce name of future combined company; Novonesis

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. Novozymes and Chr. Hansen have announced that the name of the future combined company will be ‘Novonesis’. Novonesis means ‘A new beginning’ and derives from the Greek word ‘genesis’. The name reflects a new era of biosolutions where innovation in biological sciences and technology will offer solutions to solve some of the biggest challenges facing humanity.